Diseases

Diseases

Dry AMD Market Set for Significant Transformation Through 2034, Driven by Novel Therapeutic Approaches and Rising Disease Awareness

The dry age-related macular degeneration treatment market is experiencing unprecedented growth, driven by increasing disease awareness, rising prevalence of age-related eye conditions, and breakthrough therapeutic developments from major pharmaceutical companies. According to DelveInsight's report, the dry AMD market in the 7MM (United States, EU5, and Japan) is expected

Diseases

Personalized Dose Reduction Strategies for Treating Axial Spondyloarthritis Show Promising Results

Research conducted at Bach Mai Hospital has revealed that personalized dose reduction strategies for biologic disease-modifying antirheumatic drugs (bDMARDs) may offer a feasible approach to maintaining clinical efficacy while reducing costs for patients with axial spondyloarthritis (AS). The study, published in BMC Rheumatology, aimed to evaluate the clinical effectiveness and